HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Govindan Ramachandran Selected Research

Silver

7/2023Morphological modification of silver nanoparticles against multi-drug resistant gram-negative bacteria and cytotoxicity effect in A549 lung cancer cells through in vitro approaches.
12/2020Biosynthesized silver nanoparticles using Caulerpa taxifolia against A549 lung cancer cell line through cytotoxicity effect/morphological damage.
11/2020Anti-cancer activity of biosynthesized silver nanoparticles using Avicennia marina against A549 lung cancer cells through ROS/mitochondrial damages.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Govindan Ramachandran Research Topics

Disease

4Lung Neoplasms (Lung Cancer)
07/2023 - 11/2020
2Neoplasms (Cancer)
12/2020 - 11/2020
1Urinary Tract Infections (Urinary Tract Infection)
12/2021
1Pneumonia (Pneumonitis)
02/2019

Drug/Important Bio-Agent (IBA)

3SilverIBA
07/2023 - 11/2020
1beta-Lactamases (beta-Lactamase)IBA
12/2021
1Volatile Oils (Essential Oils)IBA
12/2020
1ScopoletinIBA
12/2020
1ChitosanIBA
12/2020
1indoleIBA
12/2020
1nordamnacanthalIBA
12/2020
1morindoneIBA
12/2020
1Biocompatible Materials (Biomaterials)IBA
12/2020
1terpinoleneIBA
12/2020
1Anti-Bacterial Agents (Antibiotics)IBA
02/2019